Previous clinical trials of dual biologic therapies have raised safety issues, but more recent, promising findings from clinical trials and case series have renewed interest in the treatment approach.
The U.S. Supreme Court sided with medical providers on June 15, 2022, after the U.S. Department of Health and Human Services (HHS) cut Medicare Part B reimbursements to healthcare providers.
The U.S. Supreme Court sided with medical providers on June 15, 2022, after the U.S. Department of Health and Human Services (HHS) cut Medicare Part B reimbursements to healthcare.